Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

Issue : PJ September 2015 online

Sort by: Newest first Oldest first A-Z Z-A

  • Local practice forum events: 10–22 September 2015 Subscription

    7 SEP 2015 16:57

    Thursday 10 September: London North

  • Accreditation for RB UK learning modules Subscription

    9 SEP 2015 15:21

    The Royal Pharmaceutical Society has accredited 16 learning modules from RB UK. The modules are available for free at www.rbforhealth.co.uk. 

  • Pfizer’s plan to reimburse GPs for extra work they undertake to protect the second medical use patent of the company’s drug Lyrica (pregablin) is under consideration by the UK pharmaceutical industry’s self-regulator. In the image, company logo of Pfizer

    Pfizer’s Lyrica GP reimbursement plan under scrutiny by industry self-regulator Subscription

    10 SEP 2015 10:37 By Debbie Andalo

    Pfizer’s plan to reimburse GPs for extra work they undertake to protect the second medical use patent of the company’s drug Lyrica (pregablin) is under consideration by the UK pharmaceutical industry’s self-regulator. 

  • Developments to The Pharmaceutical Journal and Clinical Pharmacist Subscription

    10 SEP 2015 16:59 By Ash Soni, Helen Gordon
    Comments (1)

    In February 2015 we sent you a survey to ask your views on The Pharmaceutical Journal and Clinical Pharmacist and how you would like to see them developed. The majority of members who responded told us that they would like a more substantial edition of The Pharmaceutical Journal, once a month, and would also like to receive a print copy of Clinical Pharmacist once a month. We have listened to feedback from members and in response ...

  • Bladder cancer learning tool from NICE Subscription

    11 SEP 2015 11:03

    The National Institute for Health and Care Excellence (NICE) has launched a new online learning tool about bladder cancer. The tool, which was developed by the Centre for Pharmacy Postgraduate Education, supports the implementation of the NICE clinical guideline on bladder cancer. It is available for free from the NICE website.  

  • Generic hydrocortisone sodium phosphate solution available Subscription

    11 SEP 2015 11:04

    Generic hydrocortisone sodium phosphate solution for injection 100mg/ml and 500mg/5ml replaces the brand Efcortesol injection from Amdipharm Mercury.

  • Generic erythromycin lactobionate available Subscription

    11 SEP 2015 11:05

    Generic erythromycin lactobionate 1g will replace the brand Erythrocin from Amdipharm Mercury from 21 September 2015.  

  • Thursday 1 October: RPS Faculty webinar Subscription

    11 SEP 2015 11:12

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘Faculty Question Time’. Find the answers to any questions you have about the Faculty such as: what is the best type of evidence? How much detail do I need to enter into my portfolio? Who should I ask to provide a peer testimonial? Do I need to cover all the competencies? Online 1–2pm. To find out more information and to register and access the webinar, visit the ...

  • Thursday 15 October: RPS Faculty webinar Subscription

    11 SEP 2015 11:13

    Royal Pharmaceutical Society (RPS) Faculty webinar, ‘Faculty Question Time’. Find the answers to any questions you have about the Faculty such as: what is the best type of evidence? How much detail do I need to enter into my portfolio? Who should I ask to provide a peer testimonial? Do I need to cover all the competencies? Online 7–8pm. To find out more information and to register and access the webinar, visit the RPS website.

  • The Drugs for Neglected Diseases initiative has announced that it aims to spend €650m to deliver treatments for up to 10 diseases. In the image, tsetse mosquitos pictured on a researcher's hand are responsible for the African sleeping sickness

    R&D plan announced for drugs for neglected diseases Subscription

    18 SEP 2015 13:45

    The Drugs for Neglected Diseases initiative, a non-profit research and development organisation, has announced that it aims to spend €650m over the next eight years to deliver 16–18 new treatments.

Show  10 per page20 per page50 per page

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.